Trials / Completed
CompletedNCT04198896
The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC)
Clinical Aspects of Atherosclerotic-Carcinogenesis Hypothesis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8,856 (actual)
- Sponsor
- Sakakibara Heart Institute · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
As previously reported (IJC Heart \& Vasculature 2017; 17: 11.), our epidemiological analysis showing high incidence of cancers in patients with atherosclerotic cardiovascular diseases as compared with those with non-atherosclerotic cardiovascular diseases may imply a clinical possibility of a role of atherosclerosis in cancer developments. In the present study, to address our hypothesis that cancer developments may come with a strength of atherosclerosis, we traced an incidence of cancers in a total of 8,856 patients with coronary artery diseases (CAD) for a median follow-up of 1,095 days (interquartile range, 719-1,469 days) using the Sakakibara Health Integrative Profile (SHIP) database.
Detailed description
In accordance with a presence or absence of poly-arterial diseases such as aortic and/or peripheral artery diseases as an indicator of a strength of atherosclerosis, an incidence of cancers and all-cause death in two cohorts of 8,140 patients with CAD-only and 716 with CAD with poly-arterial diseases were evaluated to track an incidence of cancers and ali-cause mortality during median follou-up periods of 3 to 4 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | incidece of cancers | With a continuous surveillance system to track all subsequent incidents of cardiovascular diseases and/or non-cardiovascular diseases via direct contact in the outpatient department, hospital records, and a mailed questionnaire at least once a year, an incidence of cancers was identified |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2019-10-01
- Completion
- 2019-10-01
- First posted
- 2019-12-13
- Last updated
- 2019-12-18
Source: ClinicalTrials.gov record NCT04198896. Inclusion in this directory is not an endorsement.